Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage: Experience of 90 cases

Acta Neurochirurgica, Supplementum

Volumn 110, Issue , 2011, Pages 179-181

  Iwabuchi, S ^a   Yokouchi, T ^a   Hayashi, M ^a   Sato, K ^a   Saito, N ^a   Hirata, Y ^a   Harashina, J ^a   Nakayama, H ^a   Akahata, M ^a   Ito, K ^a   Kimura, H ^a   Aoki, K ^a  

^a TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

Author keywords

Fasudil hydrochloride; Intra arterial administration; Vasospasm

Indexed keywords

FASUDIL;

BLOOD PRESSURE; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DRUG EFFICACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; SIDE EFFECT; SUBARACHNOID HEMORRHAGE;

EID: 85052610354     PISSN: 00651419     EISSN: 00016268     Source Type: Book Series    
DOI: 10.1007/978-3-7091-0356-2_33     Document Type: Conference Paper

References (12)

1. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol. 1989;98:1091-1100
2. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1995;16:27-38
3. Hoh BL, Ogilvy CS. Endovascular treatment of cerebral vasospasm: Transluminal balloon angioplasty, intra-Arterial papaverine, and intra-Arterial nicardipine. Neurosurg Clin N Am. 2005;16: 501-516
4. Ito K, Shimomura E, Iwanaga T, Shiraishi M, Shindo K, Nakamura J, et al. Essential role of rho kinase in the Ca2 sensitization of prostaglandin F2a-induced contraction of rabbit aortae. J Physiol. 2003;546:823-836
5. Iwabuchi S, Yokouchi T, Hayashi M, Uehara H, Ueda M, Samejima H. Intra-Arterial administration of fasudil hydrochloride for vasospasm following subarachnoid hemorrhage: Analysis of timedensity curve with digital subtraction angiography. Neurol Med Chir (Tokyo). 2006;46:535-540
6. Jannett B, Bond M. Assessment of outcome after severe brain damage. A practical scale. Lancet 1975;1:480-484
7. Masaoka H, Takasato Y, Nojiri T, Hayakawa T, Akimoto H, Yatsushige H, et al. Clinical effect of Fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage. Acta Neurochir Suppl (Wien). 2001;77:209-211
8. Mathis JM, Jensen ME, Dion JE. Technical considerations on intra-Arterial papaverine hydrochloride for cerebral vasospasm. Neuroradiology 1997;39:90-98
9. Satoh S, Yamamoto Y, Toshima Y, Ikegaki I, Asano T, Suzuki Y, et al. Fasudil, a protein kinase inhibitor, prevents the development of endothelial injury and neutrophil infiltration in a two-haemorrhage canine subarachnoid model. J Clin Neurosci. 1999;6:394-399
10. Seto M, Takuwa Y, Sasaki Y. The molecular mechanism of vasospasm and the attenuation by fasudil. Nippon Yakurigaku Zasshi. 1992;114:66-70
11. Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1992;76:571-577
12. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res. 1999;43:1029-1039